Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Respiratory therapeutics.

D M Boothe1, B C McKiernan

  • 1Department of Veterinary Physiology and Pharmacology, Texas A&M University College of Veterinary Medicine, College Station.

The Veterinary Clinics of North America. Small Animal Practice
|September 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacokinetics of Single Oral Dose Extended-Release Levetiracetam in Healthy Cats.

Journal of veterinary internal medicine·2017
Same author

Pharmacokinetics and dynamics of mycophenolate mofetil after single-dose oral administration in juvenile dachshunds.

Journal of veterinary pharmacology and therapeutics·2017
Same author

Disposition of levetiracetam in healthy adult horses.

Journal of veterinary pharmacology and therapeutics·2017
Same author

Pharmacokinetics and pharmacodynamics of butorphanol in llamas following intravenous and intramuscular administration.

Veterinary anaesthesia and analgesia·2017
Same author

Behavioral changes and pharmacokinetics of butorphanol in goats following intravenous and intramuscular administration.

Veterinary anaesthesia and analgesia·2017
Same author

Disposition of Extended Release Levetiracetam in Normal Healthy Dogs After Single Oral Dosing.

Journal of veterinary internal medicine·2015
Same journal

Practical Steps Toward Antimicrobial Stewardship for the General Practitioner.

The Veterinary clinics of North America. Small animal practice·2026
Same journal

Using Evidence-Based Veterinary Medicine and Artificial Intelligence to Support Clinical Decision Making in Veterinary Practice.

The Veterinary clinics of North America. Small animal practice·2026
Same journal

Feline Asthma-Update on Diagnosis and Treatment Recommendations.

The Veterinary clinics of North America. Small animal practice·2026
Same journal

Disease Prediction and Precision Veterinary Medicine: Applications, Opportunities, and Limitations of Artificial Intelligence in Small Animal Practice.

The Veterinary clinics of North America. Small animal practice·2026
Same journal

The Moving Target of Companion Animal Infectious Diseases: Emerging Threats and Evolving Solutions.

The Veterinary clinics of North America. Small animal practice·2026
Same journal

Challenging Gram-negative Infections: Perspectives from a Clinician and a Microbiologist.

The Veterinary clinics of North America. Small animal practice·2026
See all related articles

Small animal respiratory disease treatment should consider inflammatory mediators, not just bronchodilators. Understanding disease pathophysiology improves drug therapy success for respiratory conditions in pets.

Area of Science:

  • Veterinary Medicine
  • Respiratory Pathophysiology

Background:

  • Current small animal respiratory disease treatment often focuses on bronchodilators.
  • Recent research highlights the critical role of inflammatory mediators in respiratory disease development.

Purpose of the Study:

  • To emphasize the importance of inflammatory mediators in small animal respiratory diseases.
  • To advocate for a pathophysiology-based approach to drug therapy.

Main Methods:

  • Review of current understanding of respiratory disease pathophysiology in small animals.
  • Analysis of the role of inflammatory mediators in disease progression.

Main Results:

  • Bronchodilators alone may not be sufficient for effective treatment.

Related Experiment Videos

  • Inflammatory mediators significantly contribute to the pathophysiology of respiratory diseases.

    • Conclusions:

    • Effective drug therapy for small animal respiratory tract diseases requires a comprehensive understanding of normal physiology and disease pathophysiology.
    • Integrating knowledge of inflammatory processes can lead to more successful treatment outcomes.